RecruitingNot ApplicableNCT05491213

TELESCOPE- TELEhealth Shared Decision-making COaching

TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary carE (TELESCOPE)


Sponsor

Rutgers, The State University of New Jersey

Enrollment

594 participants

Start Date

Feb 14, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Hypothesis 1a: The investigators anticipate that navigator decision coaching, compared to enhanced usual care (EUC) will result in higher quality SDM for lung cancer screening (LCS )(primary outcome), greater knowledge of lung cancer screening benefits and harms, and lower decisional conflict. Hypothesis 1b: Compared to enhanced usual care (EUC), we expect that TELESCOPE will result in more screening discussions, increased initial for lung cancer screening (LCS) with low-dose CT scan (LDCT) uptake among interested participants, increased adherence to repeat LCS and diagnostic testing, and increased smoking cessation referrals for current smokers. Hypothesis 2: The investigators expect that a "booster" coaching session will increase adherence to repeat lung cancer screening (LCS).


Eligibility

Min Age: 18 Years

Inclusion Criteria13

  • Eligibility of patients for the cluster randomized trial will follow United States Preventive Services Task Force criteria for lung cancer screening. Specifically, patients must:
  • Be 50 to 77 years of age
  • Be a current or former smoker having quit within the past 15 years
  • Have at least a 20 pack-year smoking history
  • Be scheduled for a non-acute care visit at one of the study sites. Interviews (N=50)
  • Participants completing the semi-structured interviews will be:
  • A practicing primary care clinician or a clinic director (n=20), nursing director, or clinic practice administrator (n=20) at one of the participating sites or a TELESCOPE study patient navigator (n=7) and nurse navigator (n = 3)
  • Age 18 or older
  • Fluent in English Online surveys (N=130)
  • Providers completing online PRISM construct surveys will be:
  • A practicing primary care provider at one of the participating sites or a TELESCOPE study navigator
  • Age 18 or older
  • Fluent in English

Exclusion Criteria11

  • \- Cluster Randomized Trial
  • Excluded will be patients who:
  • Do not speak English
  • Have a history lung cancer
  • Were screened for lung cancer within the past 12 months
  • Have health conditions that make them poor candidates for curative treatment as determined by the primary care provider
  • Are unable to provide informed consent Interviews (N=50)
  • Providers/administrators will be excluded if they:
  • Are unable to provide informed consent Online surveys (N=130)
  • Are unable to provide informed consent
  • Women who are pregnant. English proficiency is required for the completion of surveys, and the intervention will be conducted in English.

Interventions

BEHAVIORALTELESCOPE, Remote Decision Coaching with Navigation Intervention

The TELESCOPE intervention involves three complementary components: 1) decision aid and coaching for LCS, 2) referral of current smokers to evidence-based smoking cessation services, and 3) for participants interested in screening, navigation to complete LCS and diagnostic testing and oncology care as needed


Locations(2)

Rutgers Cancer Institute

New Brunswick, New Jersey, United States

The University of Texas MD Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05491213


Related Trials